Biotest AG
XETRA:BIO

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO
Watchlist
Price: 42.4 EUR Market Closed
Market Cap: 1.6B EUR

Intrinsic Value

The intrinsic value of one BIO stock under the Base Case scenario is 31.95 EUR. Compared to the current market price of 42.4 EUR, Biotest AG is Overvalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIO Intrinsic Value
31.95 EUR
Overvaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Biotest AG

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
BIO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for BIO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Biotest AG
XETRA:BIO
DE
Biotechnology
Market Cap
1.7B EUR
IPO
Oct 14, 1987
DE
Biotechnology
Market Cap
1.7B EUR
IPO
Oct 14, 1987
Price
false
EPS
false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BIO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Biotest AG
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biotest AG

Current Assets 704.5m
Cash & Short-Term Investments 37.8m
Receivables 171.8m
Other Current Assets 494.9m
Non-Current Assets 642.2m
Long-Term Investments 26.5m
PP&E 573.9m
Intangibles 16.4m
Other Non-Current Assets 25.4m
Efficiency

Free Cash Flow Analysis
Biotest AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Biotest AG

Revenue
707m EUR
Cost of Revenue
-467m EUR
Gross Profit
240m EUR
Operating Expenses
-150.8m EUR
Operating Income
89.2m EUR
Other Expenses
-20.7m EUR
Net Income
68.5m EUR
Fundamental Scores

BIO Profitability Score
Profitability Due Diligence

Biotest AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
Positive Gross Profit
ROIC is Increasing
Positive 3-Years Revenue Growth
48/100
Profitability
Score

Biotest AG's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

BIO Solvency Score
Solvency Due Diligence

Biotest AG's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
43/100
Solvency
Score

Biotest AG's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIO Price Targets Summary
Biotest AG

There are no price targets for BIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one BIO stock?

The intrinsic value of one BIO stock under the Base Case scenario is 31.95 EUR.

Is BIO stock undervalued or overvalued?

Compared to the current market price of 42.4 EUR, Biotest AG is Overvalued by 25%.

Back to Top